AlphaCentric Advisors »

Cullinan Oncology shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $286k 20k 14.21
2025-12-31 $197k 19k 10.35

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Astrazeneca Ord (AZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Euronet Worldwide (EEFT)
Invitation Homes (INVH)
Ionis Pharmaceuticals (IONS)
Insmed Com Par $.01 (INSM)
Incyte Corporation (INCY)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
AMREP Corporation (AXR)
Saul Centers (BFS)

View all positions for AlphaCentric Advisors

Top funds holding Cullinan Oncology

Lynx1 Capital Management
MPM Oncology Impact Management
BVF
BlackRock
Vanguard Group
Kynam Capital Management
Vanguard Capital Management
Blue Owl Capital Holdings
State Street Corporation
Affinity Asset Advisors
Rtw Investments
VR Adviser
Geode Capital Management
Siren
Nextech Invest

View all funds holding Cullinan Oncology